Life Science and Chemical Instrumentation Market: Estimated 6.9% CAGR to 2019, Says a New Research Report Available at RnRMarketResearch.com

DALLAS, April 9, 2015 /PRNewswire/ --

Global life science and chemical instrumentation market over the forecast period of 2014 to 2019. The market is expected to reach $48.84 billion by 2019, at CAGR of 6.9% from 2014 to 2019.

The global life science and chemical instrumentation market is estimated to grow at a CAGR of 6.9% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the global life science and chemical instrumentation market in 2014, the Asia-Pacific region is poised to grow at the highest rate in the next five years. Factors such as strategic expansion by key market players in emerging Asian countries; growing pharmaceutical and bio pharmaceutical industry; rising government investments in biomedical industry in China and Singapore, and extensive crop research in Asia to feed its increasing population are propelling the demand of the life science and chemical instrumentations in Asia-Pacific region. Complete report on Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019 is available at http://www.rnrmarketresearch.com/life-science-and-chemical-instrumentation-market-2011-2016-spectroscopy-chromatography-dna-sequencer-amplifier-lab-automation-array-flow-cytometer-electrophoresis-immuno-assay-others-market-report.html .

The growth of the global life science and chemical instrumentation market is driven by factors such as rising pharmaceutical R&D investments in emerging countries, increasing food safety concerns, availability of public and private funding for life science research studies, advancements in analytical instruments in terms of technology, miniaturization of instruments, and stringent drug development regulations in developed countries. In addition, emerging economies and increasing demand of analytical instruments from applied markets are creating new growth opportunities for the life science and chemical instrumentation manufacturers. Nonetheless, the high cost of technologically advanced instruments, scarcity of skilled professionals, and presence of alternative analytical technologies are the key reasons hampering the growth of life science and chemical instrumentation market.

The global life science and chemical instrumentation market is fragmented and competitive with a large number of global and local manufacturers of analytical instruments. Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.) are some of the key players in the global life science and chemical instrumentation market.  New product launches, partnerships, agreements, collaborations, and geographic expansion swere the major strategies adopted by most of the market players to achieve growth in the life science and chemical instrumentation market.

Order a copy of this research report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=61618 .

In this report, the life science and chemical instrumentation market has been segmented on the basis of technology(covering chromatography, electrophoresis, DNA sequencers & amplifiers, lab automation, spectroscopy, immunoassay, microarray, flow cytometry, and other instruments (incubators, lab balances, fume hoods, and centrifuges)), by end user(including pharmaceutical, bio pharmaceutical, and biotechnology companies; clinical research organizations (CROs); research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; and environmental testing industry; among others), and by region (North America, Europe, Asia Pacific, andRest of the World).The spectroscopy market commanded the largest share of the global life science and chemical instrumentation market in 2014. However, the DNA sequencers and amplifiers market is expected to grow at the highest rate during the forecast period. Development of technologically advanced cost efficient genome sequencers and amplifiers is the key factor driving the growth of this market segment.

Geographically, North America (comprising the U.S. and Canada) commanded the largest share of the global life science and chemical instrumentation market in 2014, followed by Europe. The North American life science and chemical instrumentation market is driven by factors such as stringent drug development regulations, public and private funding for life science research activities, growing number of metabolomics research studies, rising prevalence of chronic diseases and aging population (that is responsible for the boostin the research on bio-based drugs), and a significant number of conferences, discussions, symposium, & seminars hosted by North America related to analytical technologies.However,increasing outsourcing of clinical research by big U.S. pharma companies to developing Asian countries and changes in the Canadian R&D tax credit program are negatively affecting the growth of the life science and chemical instrumentation market in North America.

This is a premium research report priced at US$ 4650 for single user PDF license, Inquire for discount on this research report @ http://www.rnrmarketresearch.com/contacts/discount?rname=61618 .

Similar Report: 

"Laboratory Information Management Systems/ LIMS Market by Product (COTS & Legacy), Delivery Mode (On-premise, Hosted, Cloud), Component (Software & Services), End User Industries (Healthcare, CRO, Petrochemical, Oil and Gas, Chemical) - Forecast to 2019" is a Dec 2014 publication of 191 pages and it says global LIMS Market is expected to reach $1,323.6million by 2019 from $848.5 million in 2014, growing at a CAGR of 9.3% from 2014 to 2019. Companies profiled in this research report are Core Informatics, Llc, LabWare, Inc., LabVantage Solutions, Inc., STARLIMS Corporation (Subsidary Of Abbott Laboratories), Thermo Fisher Scientific, Inc., Autoscribe Informatics, Inc. (A Wholly Owned Subsidiary Of Autoscribe Ltd), Computing Solutions, Inc. (CSI), Genologics, LabLynx, Inc., and PerkinElmer, Inc. Complete report available at http://www.rnrmarketresearch.com/laboratory-information-management-systems-lims-market-by-product-cots-legacy-delivery-mode-on-premise-hosted-cloud-component-software-services-end-user-industries-healthcare-cro-pet-market-report.html .

Explore more research report on 'Life Sciences Market' @ http://www.rnrmarketresearch.com/reports/life-sciences .

Explore more Agriculture Biotechnology Market Research Reports at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/agriculture-biotechnology.

About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:

G+ / Google Plus:https://plus.google.com/u/0/104156468549256253075/   

Twitter:https://twitter.com/#!/RnRMR  

Facebook:http://www.facebook.com/pages/RnR-Market-Research/413488545356345   

RSS / Feeds:http://www.rnrmarketresearch.com/feed

Contact:  
Siju K.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@rnrmarketresearch.com